Cisplatin and Pemetrexed for Lung Cancer and Pleural Mesothelioma

2008 ◽  
Vol 43 (10) ◽  
pp. 800-805
Author(s):  
Dominic A. Solimando ◽  
Kajal Patel ◽  
J. Aubrey Waddell
Keyword(s):  
Lung Cancer ◽  
Antineoplastic Therapy ◽  
Cancer Chemotherapy ◽  
Pleural Mesothelioma ◽  
Malignant Diseases ◽  
Toxic Agents

The complexity of cancer chemotherapy requires that pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy and the agents, both commercially available and investigational, used to treat malignant diseases.

Irinotecan and Carboplatin (IC) Regimen for Lung Cancer

2009 ◽  
Vol 44 (9) ◽  
pp. 740-745
Author(s):  
J. Aubrey Waddell ◽  
Dominic A. Solimando
Keyword(s):  
Lung Cancer ◽  
Antineoplastic Therapy ◽  
Cancer Chemotherapy ◽  
Malignant Diseases ◽  
Toxic Agents

The complexity of cancer chemotherapy requires that pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparing, dispensing, and administering antineoplastic therapy and to the agents, commercially available and investigational, used to treat malignant diseases.

scholarly journals Docetaxel and Cisplatin Regimen for Non-Small-Cell Lung Cancer

2013 ◽  
Vol 48 (7) ◽  
pp. 550-557 ◽  
Author(s):  
Jessie Yang ◽  
Dominic A. Solimando ◽  
J. Aubrey Waddell
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Antineoplastic Therapy ◽  
Cancer Chemotherapy ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Malignant Diseases ◽  
Small Cell Lung ◽  
Toxic Agents

The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

scholarly journals Carboplatin (Renally Dosed) and Etoposide Regimen for Small-Cell Lung Cancer

2013 ◽  
Vol 48 (4) ◽  
pp. 274-279 ◽  
Author(s):  
Matthew R. Rutledge ◽  
J. Aubrey Waddell ◽  
Dominic A. Solimando
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Antineoplastic Therapy ◽  
Cancer Chemotherapy ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Malignant Diseases ◽  
Small Cell Lung ◽  
Toxic Agents

The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

BEACOPP(baseline) Regimen for Hodgkin Lymphoma

2009 ◽  
Vol 44 (8) ◽  
pp. 662-669 ◽  
Author(s):  
Dominic A. Solimando ◽  
J. Aubrey Waddell
Keyword(s):  
Hodgkin Lymphoma ◽  
Antineoplastic Therapy ◽  
Cancer Chemotherapy ◽  
Malignant Diseases ◽  
Toxic Agents

The complexity of cancer chemotherapy requires that pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparing, dispensing, and administering antineoplastic therapy and to the agents, commercially available and investigational, used to treat malignant diseases.

Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Regimen for Multiple Myeloma

2011 ◽  
Vol 46 (11) ◽  
pp. 839-847
Author(s):  
K. Morrison Erin ◽  
J. Aubrey Waddell ◽  
A. Solimando Dominic
Keyword(s):  
Multiple Myeloma ◽  
Antineoplastic Therapy ◽  
Cancer Chemotherapy ◽  
Malignant Diseases ◽  
Toxic Agents

The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

scholarly journals Idelalisib and Rituximab Regimen

2017 ◽  
Vol 52 (3) ◽  
pp. 187-190 ◽  
Author(s):  
A. Kacee Barnett ◽  
J. Aubrey Waddell ◽  
Dominic A. Solimando
Keyword(s):  
Antineoplastic Therapy ◽  
Cancer Chemotherapy ◽  
Malignant Diseases ◽  
Toxic Agents

The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

scholarly journals Procarbazine, Lomustine, and Vincristine (PCV) Regimen for Central Nervous System Tumors

2017 ◽  
Vol 52 (2) ◽  
pp. 98-104 ◽  
Author(s):  
Dominic A. Solimando ◽  
J. Aubrey Waddell
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Antineoplastic Therapy ◽  
Cancer Chemotherapy ◽  
Central Nervous System Tumors ◽  
Malignant Diseases ◽  
Nervous System Tumors ◽  
Toxic Agents

The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

Gemcitabine and Erlotinib (GE) Regimen for Pancreatic Cancer

2012 ◽  
Vol 47 (1) ◽  
pp. 19-23 ◽  
Author(s):  
Jessica N. Lee ◽  
J. Aubrey Waddell ◽  
A. Solimando Dominic
Keyword(s):  
Pancreatic Cancer ◽  
Antineoplastic Therapy ◽  
Cancer Chemotherapy ◽  
Malignant Diseases ◽  
Toxic Agents

The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

scholarly journals Pentostatin, Cyclophosphamide and Rituximab (PCR) Regimen

2016 ◽  
Vol 51 (11) ◽  
pp. 888-893 ◽  
Author(s):  
Dominic A. Solimando ◽  
J. Aubrey Waddell
Keyword(s):  
Antineoplastic Therapy ◽  
Cancer Chemotherapy ◽  
Malignant Diseases ◽  
Toxic Agents

The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

Degarelix Plerixafor

2009 ◽  
Vol 44 (5) ◽  
pp. 386-389
Author(s):  
J. Aubrey Waddell ◽  
Dominic A. Solimando
Keyword(s):  
Antineoplastic Therapy ◽  
Cancer Chemotherapy ◽  
Malignant Diseases ◽  
Toxic Agents

The complexity of cancer chemotherapy requires that pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparing, dispensing, and administering antineoplastic therapy and to the agents, commercially available and investigational, used to treat malignant diseases.

Sign in / Sign up

Export Citation Format

Share Document